Catherine Agoropoulou

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

Ludwig Kappos, Ernst‐Wilhelm Radue, Paul O’Connor et al. · New England Journal of Medicine · 2010 · 2.6K citations · Full text

Life Sciences, Neurology, Pharmacotherapy +14

Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study

V. Devonshire, Eva Havrdová, Ernst W. Radue et al. · The Lancet Neurology · 2012 · 182 citations

Medicine, Neurology, Disability Management +12

Optical coherence tomography in multiple sclerosis: A 3‐year prospective multicenter study

Friedemann Paul, Peter A. Calabresi, Frederik Barkhof et al. · Annals of Clinical and Translational Neurology · 2021 · 95 citations · Full text

Medicine, Neurology, Neuroscience +17

Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial

Richard AC Hughes, Marinos C. Dalakas, Ingemar S. J. Merkies et al. · The Lancet Neurology · 2018 · 74 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +9

Long-Term Efficacy and Safety of Fingolimod (FTY720) in Relapsing-Remitting Multiple Sclerosis (RRMS): Results from the Extension of the Phase III FREEDOMS Study (S41.004)

L Kappos, EW Radue, P. O’Connor et al. · Neurology · 2012 · 12 citations

Pharmacy, Neurology, Pharmacotherapy +13